Drug development and the cellular quality control system
Authors:
- P. Michael ConnPCP. Michael Conn
- Jo Ann JanovickJJJo Ann Janovick
- 1 May 2009
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 30 (5) , 228-233
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Trafficking and quality control of the gonadotropin releasing hormone receptor in health and diseaseMolecular and Cellular Endocrinology, 2009
- Molecular Mechanism of Action of Pharmacoperone Rescue of Misrouted GPCR Mutants: The GnRH ReceptorMolecular Endocrinology, 2009
- Increased plasma membrane expression of human follicle-stimulating hormone receptor by a small molecule thienopyr(im)idineMolecular and Cellular Endocrinology, 2009
- Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuriaJournal of Clinical Investigation, 2008
- β‐Galactosidase deficiency: An approach to chaperone therapyJournal of Inherited Metabolic Disease, 2006
- Therapy through chaperones: Sense or antisense? Cystic fibrosis as a model diseaseJournal of Inherited Metabolic Disease, 2006
- Inefficient Maturation of the Rat Luteinizing Hormone ReceptorJournal of Biological Chemistry, 2005
- Modulation of neurodegeneration by molecular chaperonesNature Reviews Neuroscience, 2005
- Pharmacological chaperones: potential treatment for conformational diseasesTrends in Endocrinology & Metabolism, 2004
- Misrouted cell surface GnRH receptors as a disease aetiology for congenital isolated hypogonadotrophic hypogonadismHuman Reproduction Update, 2004